Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand 
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
BHP Posts Record Iron Ore Output as China Pricing Pressures Loom 
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10% 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
Brazil Supreme Court Orders Asset Freeze of Nelson Tanure Amid Banco Master Investigation 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York 
Proposed Rio Tinto–Glencore Merger Faces China Regulatory Hurdles and Asset Sale Pressure 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
WATERTOWN, Mass., April 25, 2017 -- Exergen Corporation announces the availability of new professional Temporal Artery Thermometer TAT-5000S models connected to leading vital signs monitors. The new TemporalScanner models are available in six different variations to meet a variety of major vital signs monitor requirements, all supporting the use and advancement of Electronic Medical Records (EMR).
The connection of the TemporalScanner, an award-winning, breakthrough medical thermometer supported by more than 70 peer-reviewed published studies for accurate, completely non-invasive temperature assessment, now eliminates the need for manual entry of data, when connected to vital signs monitors. This significantly aids in the organization, security and confidentiality of patient records. In addition, the connected Exergen TAT models provide convenience and speed for the clinician.
“Through the addition of these new models, we are able to meet the demands of hospitals and clinics for fast, accurate, non-invasive thermometers connected to vital signs monitors, which all automatically record patient data, saving time, improving record accuracy and security, and reducing costs,” said Francesco Pompei, Ph.D., CEO of Exergen Corporation. “Our focus on patient comfort and security speaks to our commitment of introducing new connected models of TATs for vital signs monitors,” added Dr. Pompei.
Exergen Corporation is dedicated to improving and increasing quality, efficiency and accuracy of temperature taking in patient records. With more than 70 published studies supporting its accuracy, the TemporalScanner helps improve patient outcomes while improving patient and clinician experience. The connected models are now available with eight leading vital signs monitors (see http://www.exergen.com//tat5000s).
ABOUT EXERGEN CORPORATION
Exergen manufactures and markets two series of the TemporalScanner thermometer: a professional version for hospitals and clinics, and a consumer version sold in major retailers nationwide. More than two billion temperatures are taken each year with TemporalScanners. Used in thousands of hospitals and clinics across the country as well as in millions of homes, TemporalScanners are the #1 preference of pediatricians, #1 preference of nurses, and #1 selling retail thermometer. The Exergen TemporalScanner's accuracy is supported by more than 70 peer-reviewed published studies covering all ages from preterm infants to geriatrics and all care areas from hospitals to homes. For additional information, visit www.exergen.com.
Contact: Victoria Day Rosica Public Relations [email protected] P: 201.843.5600 F: 201.843.5680 21-00 Route 208 South Fair Lawn, NJ 07410
